Under the corporate philosophy of “Dedicated to the Fight Against Disease...
Overall Picture of Environmental Impact (ONO's Involvement in Enviro...
There are considered to be approximately 250,000 children under l...
Analysis and Evaluation of Risks and Opportunities related to Climate Ch...
Please refer to the “Corporate Governance Report” below for details on ou...
Dissemination of Medical Information "The Moment of Change (Cancer Sur...
Global Environment Policy Medium- to Long-term Environmental Vision ...
We agree with the purport of the "Council on Promoting Partnership Buildi...
We engage in environment-related education and awareness-raising activ...
The Ono Pharmaceutical Group's performance may be significantly affected ...
Governance We recognize the preservation of the global environment as ...
Creating a road map for reduction of GHG emissionsActions against TCFD ri...
In September 2023, ONO joined PSCI (Pharmaceutical Supply Chain In...
We have been producing a radio program called "The Moment of Change" sinc...
Following the revision of the Curriculum Guidelines by the Ministry of Ed...
On November 12, 2021, we concluded an agreement with Osaka Prefect...
Approach to Social Contribution Activities ONO’s Social Contribution A...
Risks and opportunities related to climate change are investigated under ...
Basic Policy for Enterprise Risk Management (ERM) In order to ensu...
Since FY2014, ONO has been a constant supporting member of a public in...
Information Disclosure IR Activities ESG Activities
